论文部分内容阅读
我们选择了目前临床应用较普遍的AFP、CEA、SF、AIF对原发性肝细胞肝癌（PLC）联合检测,就其对PLC的诊断价值进行探讨。 材料和方法 一、对象:正常对照组100例（男性健康体检者,年龄25～57岁,平均34.75岁）;PLC患者73例,为无锡市太湖肿瘤医院住院男性患者,年龄23～77岁,平均53.03岁,其诊断符合全国肝癌协作组（1977年）标准,部分经手术或病理证实。 二、方法:AFP试剂盒为上海生物制品研究所产品,CEA、SF试剂盒为中国原子能科学研究院产品,AIF试剂盒为核医学国家重点实验室产品。均按试剂盒说明书操作。 结果和讨论 一、正常对照组及PLC患者血清肿瘤标志物测定结果见表1。
We have selected the most commonly used clinical application of AFP, CEA, SF, AIF detection of primary hepatocellular carcinoma (PLC), its diagnostic value of PLC. Materials and Methods First, the object: normal control group of 100 patients (male health examination, aged 25 to 57 years, average 34.75 years); PLC patients 73 cases, Taihu Cancer Hospital in Wuxi male hospitalized patients, aged 23 to 77 years, Average 53.03 years old, the diagnosis consistent with the National Cooperative Group of Liver Cancer (1977) standards, some confirmed by surgery or pathology. Second, methods: AFP kit for the Shanghai Institute of Biological Products, CEA, SF kits for the China Institute of Atomic Energy products, AIF kit for the State Key Laboratory of nuclear medicine products. According to kit instructions. Results and discussion First, the normal control group and PLC patients serum tumor markers in Table 1.